Genialis™ krasID White Paper
Explore the full story behind the science and innovation [...]
Launching products in healthcare: The most important framework is flexibility | TPM podcast #49
Upcoming events Genialis on LinkedIn [...]
How to have the biggest impact on patients: a career of invention, innovation, and implementation | TPM podcast #48
Genialis presents a poster at ISMB/ECCB 2025 [...]
Assessing confidence in genetic variants identified in RNA-seq data
RNA-seq data hold significant potential for identifying genetic variants. [...]
Genialis CTO Dr. Miha Štajdohar joins EU AI action plan roundtable
Dr. Miha Štajdohar, CTO and co-founder of Genialis, was [...]
A new paradigm for generative AI drug discovery: more accurate shots on a much wider goal | TPM podcast #47
Move Fast and Try Not to Break Things: AI [...]
Large scale gene set ranking for survival-related gene sets
Abstract:Disease progression is closely linked to shifts in the [...]
Advantages of RNA in oncology R&D: Genialis’ CEO joins Tempus’ webinar
At the end of May, Genialis CEO Rafael Rosengarten, [...]
Prediction of sotorasib response duration and identification of clinically actionable resistance mechanisms using an RNA-based patient classifier
KRAS mutations are among the most prevalent oncogenic drivers [...]
Precision medicine is our future and our fate | TPM podcast #46
Tempus’ live webinar featuring Rafael Rosengarten [...]
